Safety of available treatment options for renal cell carcinoma-Reference-Cited by-同舟云学术

Safety of available treatment options for renal cell carcinoma

Published:2016-05-23 Issue:8 Volume:15 Page:1097-1106
ISSN:1474-0338
Container-title:Expert Opinion on Drug Safety
language:en
Short-container-title:Expert Opinion on Drug Safety

Author:

Derosa Lisa¹,Albiges Laurence¹,Massard Christophe¹,Loriot Yohann¹,Fizazi Karim¹,Escudier Bernard¹

Affiliation:

1. Gustave Roussy Cancer Campus

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14740338.2016.1184643

Reference78 articles.

1. Immunotherapy for advanced renal cell cancer

2. Tumor Angiogenesis

3. Renal-Cell Carcinoma — Molecular Pathways and Therapies

4. European Medicines Agency - Find medicine - Nexavar [Internet]. Available from: http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000690/human_med_000929.jsp&mid=WC0b01ac058001d124

5. European Medicines Agency - Find medicine - Sutent [Internet]. Available from: http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000687/human_med_001069.jsp&mid=WC0b01ac058001d124

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cancers du rein et des voies urinaires;Ciblage Thérapeutique en Oncologie;2023

2. Designing novel immunocombinations in metastatic renal cell carcinoma;Immunotherapy;2020-12

3. Sarcomatoid renal cell carcinoma: biology, natural history and management;Nature Reviews Urology;2020-10-13

4. Long non-coding RNA TCL6 enhances preferential toxicity of paclitaxel to renal cell carcinoma cells;Journal of Cancer;2020

5. Therapeutic Drug Monitoring of Targeted Therapy in Metastatic Renal Cell Carcinoma;Protein & Peptide Letters;2018-08-28